<DOC>
	<DOCNO>NCT00467688</DOCNO>
	<brief_summary>The objective cross study access continuous glucose monitoring ( CGMS ) real time fee back hypoglycemic well hyperglycemic glucose alert vs. retrospective analysis glucose value able improve course glucose special regard time spend hypoglycemic glucose range type 1 diabetic patient impaired hypoglycemia awareness history severe hypoglycemia . The second objective access satisfaction CGMS condition</brief_summary>
	<brief_title>Effect Continuous Glucose Monitoring Course Glucose Type 1 Diabetes</brief_title>
	<detailed_description>The objective cross study access continuous glucose monitoring ( CGMS ) real time fee back hypoglycemic well hyperglycemic glucose alert vs. retrospective analysis glucose value able improve course glucose special regard time spend hypoglycemic glucose range . The second objective access satisfaction CGMS condition . This study conduct inpatient set type 1 diabetic patient . Partisans ask twice continuous glucose measurement GlucoDay System ( Menarini Diagnostics ) . Each measurement period limit maximal 48 hour . In one condition real time access current glucose value alert give glucose drop 70 mg/dl exceed 180 mg/dl . During condition participant blind current glucose value alert give . Glucose course retrospectively analyze . The order two condition randomize . Expected outcome : The primary outcome variable daily time spend hypoglycemic range type 1 diabetic patient without impaired hypoglycemia awareness history severe hypoglycemia . Additionally patient also complete questionnaire satisfaction CGMS , diabetes related distress , treatment satisfaction , depressive anxiety symptom belongs secondary variable . Inclusion criterion : - Type 1 diabetes - Age &gt; 18 year - Informed consent Exclusion criterion : - Diagnosis and/or treatment current psychiatric disease - Severe late complication</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>type 1 diabetes Age &gt; 18 year Informed consent Diagnosis and/or treatment current psychiatric disease Severe late complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>glucose excursion</keyword>
	<keyword>hypoglycemia awareness</keyword>
	<keyword>continuous glucose monitoring</keyword>
</DOC>